Extension Study of BIIB092 in Participants With Progressive Supranuclear Palsy (PSP) Who Participated in CN002003
Stopped early · Phase 1
Conditions studied: Supranuclear Palsy, Progressive
In brief
The purpose of this study is to evaluate the long-term safety and tolerability of multiple intravenous (IV) infusions of BIIB092 in participants with Progressive Supranuclear Palsy (PSP). The study will also assess the pharmacodynamic (PD) effects of BIIB092 on cerebrospinal fluid (CSF) N-terminal tau, pharmacokinetics (PK), and immunogenicity of BIIB092 in participants with PSP.
Key facts
- Study ID
- NCT02658916
- Run by
- Biogen
- People needed
- 47
- Starts
- 2016-02-22
- Expected to finish
- 2020-03-31
- Last updated by the study team
- 2020-05-18
Who can join
Age: 41 and older, up to 86. Sex: any. Healthy volunteers: not accepted.
Where it is running
- The University of Alabama at Birmingham — Birmingham, Alabama, United States
- University of California San Diego — La Jolla, California, United States
- David Geffen School of Medicine at UCLA — Los Angeles, California, United States
- University of California, San Francisco, Medical Center at Parnassus — San Francisco, California, United States
- Parkinson's Disease and Movement Disorders Center of Boca Raton, Inc. — Boca Raton, Florida, United States
- University of Florida College of Medicine — Gainesville, Florida, United States
- University of South Florida — Tampa, Florida, United States
- The University of Chicago Medical Center — Chicago, Illinois, United States
- University of Minnesota Medical School — Minneapolis, Minnesota, United States
- Robert Wood Johnson Medical School — New Brunswick, New Jersey, United States
- Columbia University Medical Center — New York, New York, United States
- Hospital of the University of Pennsylvania — Philadelphia, Pennsylvania, United States
- The University of Texas Southwestern Medical Center — Dallas, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.